AI

AB Ility

Description

AB Ility is an invesment comapny.

Investor Profile

AB Ility has backed more than 2 startups, with 1 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Convertible Note rounds (top funding stages).
  • Majority of deals are located in Sweden.
  • Strong thematic focus on Biotechnology, Health Care, Pharmaceutical.

Stage Focus

  • Convertible Note (100%)

Country Focus

  • Sweden (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does AB Ility frequently co-invest with?

Karolinska
Europe, Stockholms Lan, Sweden, Solna
Co-Investments: 2
R
Europe, Stockholms Lan, Sweden, Stockholm
Co-Investments: 2

What are some of recent deals done by AB Ility?

Umecrine Cognition

Solna, Stockholms Lan, Sweden

Umecrine Cognition is a developer of pharmaceutical products to treat cognitive neurological disorders.

BiotechnologyHealth CarePharmaceutical
Convertible NoteJul 14, 2025
Amount Raised: $2,564,106
Umecrine Cognition

Solna, Stockholms Lan, Sweden

Umecrine Cognition has develops drugs against central nervous system neurological disorders, CNS caused by endogenous CNS active steroids.

BiotechnologyHealth CarePharmaceutical
Convertible NoteDec 19, 2024
Amount Raised: $2,157,497
Umecrine Cognition

Solna, Stockholms Lan, Sweden

Umecrine Cognition has develops drugs against central nervous system neurological disorders, CNS caused by endogenous CNS active steroids.

BiotechnologyHealth CarePharmaceutical
Convertible NoteNov 17, 2023
Amount Raised: $2,869,557